Asset Comparison and Correlation

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 7, 2012.

RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

By Auxilium Pharmaceuticals, Inc. MALVERN, Pa., Feb. 9, 2012 -- /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter 2011 on Thursday, February 23, ...

Andrew I. Koven Named Executive Vice President, Chief Administrative Officer and General Counsel, Mark A. Glickman Named Senior Vice President, Sales, By Auxilium Pharmaceuticals, Inc. MALVERN, Pa.

By Derek Hoffman Dendreon Corp. (NASDAQ:DNDN): Cantor believes John Johnson's background in marketing and cost structure could lead to a restructuring within Dendreon in 2012.

By Derek Hoffman Dendreon Corp.(NASDAQ:DNDN): Deutsche Bank said Dendreon's new CEO, John Johnson, has a history of M&A and his fresh perspective might benefit the company's near-term strategy.